Halberd Corporation: Halberd Pre-Clinical Test Protocol Approved
Testing of Nasal Spray to Counteract the Effects of Head Trauma to Begin by Month's EndJACKSON CENTER, PA / ACCESSWIRE / May 9, 2023 / Halberd Corporation (OTC PINK:HALB) researchers at Mississippi State